Nahdi Medical Company · TADAWUL:4164
Nahdi Medical — Q2 2026 Earnings Presentation
20 slides from Nahdi Medical's earnings presentation, Jul 30, 2026
Slide 1: Nahdi Medical Company Investor Presentation Q2 2026
INVESTOR PRESENTATION Nahdi Medical Company Q2 2026 Nahdi Medical Company | Q2 2026 EARNINGS CALL
Slide 2: H1 2026 Financial Highlights
H1 2026 Financial Highlights (% of revenue) H1 2026 % Change H1 2025 Revenue 5.47B 5.9% 5.16B RESILIENT FINANCIAL Gross Profit 1,995M (36.5%) 4.5% 1,910M (37.0%) PERFORMANCE Operating Profit 506M (9.2%) -4.7% 531M (10.3%) Net Profit 451M (8.2%) -8.6% 494M (9.6%) EBITDA 911M (16.7%) -0.6% 917M (17.8%
Slide 3: Solid Revenue Growth Across Businesses & Categories
Solid Revenue Growth Across Businesses & Categories Pharmacies 1,181 1,222 1,207 1,217 Revenue grew by 5.9 % YoY in H1 2026, increasing by 306 million, Clinics 10 14 12 14 driven by strong growth momentum across all business segments M Retail business rose by 4.4% fueled 9,446 10,213 by continued gr
Slide 4: Diversified Sales Channel Growth Driving Top-Line Acceleration
Diversified Sales Channel Growth Driving Top- 6,000 Line Acceleration M +4.4% +34.6% +28% +5.9% 223 57 26 5,469 5,163 5,000 The Retail business continued to lead the overall growth 4,000 Contribution from Healthcare and Regional expansion business increased to 6% up 94% 95% from 5% same period last
Slide 5: Best in Class Operating Profit Margin
Best in Class Operating Profit Margin Operating profit impacted by Operating Margin 9.2% 9.1% 10.3% 9.2% continued investments to support revenue growth The gross profit increased by 4.5%, while gross margin stood at 36.5% reflecting the M change in business mix with the accelerated growth in health
Slide 6: Attractive Net Profit Profile
Net Profit/ Revenue Attractive Net Profit Profile 8.7% 8.1% 9.6% 8.2% Net profit landed at 451 million, reflecting an 8.2% margin Overall, the Company’s net profit M declined by 5.2% compared to the same period last year, while the year-on-year 821 831 comparison reflects a decline of 8.6%, due to o
Slide 7: 2026 Guidance
Guidance 2026 Guidance Total revenue Growth 6% - 8% EPS Growth 1% - 2% Capex ~4% Dividend Policy 75% - 85% The 2026 full-year guidance remains subject to review in Q3 2026 considering the evolving macroeconomic and geopolitical developments Nahdi Medical Company | Q2 2026 EARNINGS CALL
Slide 8: Strategy & Operational Review
Strategy & Operational Review Nahdi Medical Company | Q2 2026 EARNINGS CALL
Slide 9: Our Passion for People
Our Passion for People Always Delivers Value to Our Guests 39.4 Nationalization % No. 1 • 1,450+ national pharmacists • Reached 44.2% feminization • ~200K hours of training conducted in Q1. Nahdi Medical Company | Q2 2026 EARNINGS CALL Awarded in 2025
Slide 10: Nahdi: Guest Satisfaction - the Cornerstone of our strategy
Nahdi: Guest Satisfaction - the Cornerstone of our strategy Stronger Brand Equity YoY Nielsen Store Equity Index ** 69.2% of revenue Q1 2025 Q1 2026 generated from Nahdi “Nuhdeek” Guests * As Q2 2026 7 6.9 Strong 3.4 3.4 89 NPS As Q2 2026 1.2 1.3 Moderate 0.9 0.9 0.7 0.7 0.3 0.3 Weak Source: Company
Slide 11: Nahdi: The Retailer Suppliers Trust, Partnering for Mutual Success
Nahdi: The Retailer Suppliers Trust, Partnering for Mutual Success Among Among Pure Omni- Players #1 In Store Retailers and Pharmacies #1 Among e-commerce #1 Rank/17 Score (100 - /100 +) Rank/19 Score 1 0 63 (100 - /100 +) Rank/9 Score (100 - /100 +) 2 3 56 1 0 59 1 63 3 7 50 2 3 49 2 50 3 12 50 3 6
Slide 12: Awards, Recognition & Market Leadership
Awards, Recognition & Market Leadership Compliance Program Completion Certificate CEO of the year - Retail Most Influential Brands in Saudi Arabia Most People to Sign Up for a Vital Signs Screening In One Week 12,493 Sign-Ups Achieved in 7 Days Nahdi Medical Company | Q2 2026 EARNINGS CALL (Targeted
Slide 13: Strategic Initiatives
Strategic Initiatives Nahdi Medical Company | Q2 2026 EARNINGS CALL
Slide 14: Market Challenges & Strategic Response
Market Challenges & Strategic Response KEY MARKET CHALLENGES MITIGATION STRATEGY & ACTIONS Softening Market Demand Guest-Centric Growth Strategy Driven by evolving shopper behavior and Strengthening guest engagement and loyalty, more cautious spending patterns delivering 130bps market share gain Cha
Slide 15: Digital Acceleration: Seamless Experiences to Fuel Nahdi's Growth
Digital Acceleration: Seamless Experiences to Fuel Nahdi’s Growth 30.2% Online contribution 25.8% 24.8% 21.7% 16% 13% 22 23 24 H1-25 25 H1-26 Nahdi Medical Company | Q2 2026 EARNINGS CALL Nahdi Medical Company | Q2 2026 EARNINGS CALL
Slide 16: Serve our Community with Purpose
Serve our Community with Purpose 90 NPS Wasfaty Transactions 2,293,952 2,291,999 Q1 2026 Q2 2026 Nahdi Medical Company | Q2 2026 EARNINGS CALL
Slide 17: Nahdi's Private Label Powerhouse; Delivering Growth & Guest Loyalty
Nahdi’s Private Label Powerhouse; Delivering Growth & VS Guest Loyalty 19.4% 17% 16.7% 13% 13% 12.50% Private Label contribution 2022 2023 2024 2025 H1 2025 H1 2026 Nahdi Medical Company | Q2 2026 EARNINGS CALL
Slide 18: Nahdi's Leap: Advancing National Healthcare Leadership
Nahdi’s Leap: Advancing National Healthcare Leadership Revenue growth momentum 350 VS M 200 222 165 101 49 2022 2023 2024 2025 H1 2025 H1 2026 Guests visits growth M 2.00 VS 1.40 1.00 0.95 1.10 0.49 2022 2023 2024 2025 H1 2025 H1 2026 Nahdi Medical Company | Q2 2026 EARNINGS CALL
Slide 19: We exist to add beats to the lives of our GUESTS
We exist to add beats to the lives of our GUESTS Nahdi Medical Company | Q2 2026 EARNINGS CALL 19
Slide 20: Thank You
Thank You Investor Relations Department Contacts: Email: IR@nahdi.sa Phone: +966 556 315 822 Nahdi Medical Company | Q2 2026 EARNINGS CALL 20
Nahdi Medical Company — Q2 2026 Earnings Presentation on 6ix